IOBT vs GILD: Which Stock is Better?

Side-by-side comparison of Io Biotech Inc and Gilead Sciences Inc in 2026

Comparison Updated:

IOBT

Io Biotech Inc

$0.01

GILD

Gilead Sciences Inc

$140.45

Key Metrics Comparison

MetricIOBTGILDWinner
Market Cap$3.45M$172.56BGILD
P/E RatioN/A20.51GILD
EPS (TTM)$N/A$6.78GILD
Revenue Growth0.0%0.0%GILD
Gross Margin0.0%78.8%GILD

Analyze IOBT

Full quant analysis

Analyze GILD

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is IOBT or GILD a better investment?

Comparing IOBT and GILD: Io Biotech Inc has a market cap of $3.45M while Gilead Sciences Inc has $172.56B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between IOBT and GILD?

IOBT (Io Biotech Inc) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: IOBT or GILD?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: IOBT or GILD?

GILD has higher revenue growth at 0.0% vs 0.0% for IOBT.

Which company is more profitable: IOBT or GILD?

Gilead Sciences Inc (GILD) has higher gross margins at 78.8% compared to 0.0% for IOBT.

Which is the larger company: IOBT or GILD?

Gilead Sciences Inc (GILD) is larger with a market cap of $172.56B compared to $3.45M for IOBT.

Should I buy IOBT or GILD in 2026?

Both IOBT and GILD have investment merit. IOBT trades at $0.01 while GILD trades at $140.45. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between IOBT and GILD stock?

Key differences: Market Cap ($3.45M vs $172.56B), P/E Ratio (N/A vs 20.5x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 78.8%).

Popular Stock Comparisons